Another intriguing, yet still not understood, aspect of this pathology is that, while ApoA-I amyloidosis is a systemic disease, the different amyloidogenic variants show a preferential tissue accumulation that clearly appears to be dependent on the location of the amino acid substitutions and on their distinctive interactions with tissue-specific extracellular milieus. Here, APOA1 is linked to amyloidosis.